Search results
Can-Fite Biopharma Ltd (CANF) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
Zacks via Yahoo Finance· 7 months agoAfter losing some value lately, a hammer chart pattern has been formed for Can-Fite Biopharma Ltd...
All You Need to Know About CanFite Biopharma Ltd (CANF) Rating Upgrade to Buy
Zacks via Yahoo Finance· 2 years agoCanFite Biopharma Ltd (CANF) might move higher on growing optimism about its earnings prospects,...
Can-Fite (CANF) Up on Liver Cancer Study Update of Namodenoson
Zacks via Yahoo Finance· 6 months agoCan-Fite (CANF) stock up 7% as the liver cancer patient achieves a complete response and overall...
Best Momentum Stocks to Buy for October 27th
Zacks via Yahoo Finance· 7 months agoHere are three stocks with buy rank and strong momentum characteristics for investors to consider today, October 27: Vertiv Holdings Co VRT: This digital...
Can-Fite's Namodenoson Increases Survival For Most Severe Patients With Advanced Liver Cancer
Benzinga via Yahoo Finance· 1 year agoCan-Fite BioPharma Ltd (NASDAQ: CANF) provided an update on its clinical program for Namodenoson for...
Can-Fite BioPharma Shares Jump After Piclidenoson Data In Psoriasis Trial
Benzinga via Yahoo Finance· 2 years agoCan-Fite BioPharma Ltd (NYSE: CANF) announced topline results from the COMFORT Phase 3 trial of...
Catalyst's (CPRX) Q3 Earnings & Revenues Surpass Estimates
Zacks via Yahoo Finance· 2 years agoCatalyst Pharmaceuticals, Inc. CPRX reported earnings of 20 cents per share for the third quarter of...
Corcept's (CORT) Q3 Earnings Beat Estimates, Revenues Miss
Zacks via Yahoo Finance· 2 years agoCorcept's (CORT) third-quarter 2022 earnings beat estimates while revenues miss the same. The...
Minerva (NERV) Down; FDA Denies Review Schizophrenia Drug NDA
Zacks via Yahoo Finance· 1 year agoMinerva (NERV) confirmed that the FDA's refuse-to-file letter on its regulatory filing, seeking...